VIGMED’S BOARD OF DIRECTORS HAS RESOLVED ON A DIRECTED NEW ISSUE OF SHARES PURSUANT TO AN AUTHORISATION GRANTED BY THE ANNUAL GENERAL MEETING
The Board of Directors of Vigmed Holding AB (publ) (“Vigmed” or the “Company”) has, pursuant to the authorisation granted by the annual general meeting on 12 May 2016, resolved on a directed new issue of 7,305,555 shares, which will raise proceeds to the Company of approximately SEK 8 million before deduction of issue costs.The board of directors has, pursuant to the authorisation granted by the annual general meeting on 12 May 2016, resolved on a directed new issue of 7,305,555 shares to its main shareholder, Greiner Bio-One GmbH (“GBO”). The shares are issued at a subscription price